|
0
|
|
A Randomized Trial to Compare Dolutegravir Plus Boosted Darunavir Versus Recommended Standard of Care Antiretroviral Regimens in People With HIV-1, Whose First-line Non-nucleoside Reverse Transcriptase Inhibitor Therapy Has Failed: Final 96-week Results of the D2EFT Study.
(academic.oup.com)
|
Nyein PP
…
Matthews GV
Clinical Infectious Diseases
2026-02-04
|
#amr
#clinical trial
#treatment
#hiv
|
|
0
|
|
Hepatitis B Virus Care Cascade in Rwanda: A Population-based Study From 2016-2023.
(academic.oup.com)
|
Makuza JD
…
Janjua NZ
Clinical Infectious Diseases
2026-02-04
|
#infection
#screening
#epidemiology
#treatment
#hepatitis
|
|
0
|
|
Short Course Therapy With Glecaprevir/Pibrentasvir for Early Hepatitis C Virus Infection: PURGE-C.
(academic.oup.com)
|
Kim AY
…
Naggie S
Clinical Infectious Diseases
2026-02-04
|
#clinical trial
#treatment
#antiviral
#hepatitis c
|
|
0
|
|
Inhaled liposomal ciprofloxacin protects against lethal tularemia in the common marmoset.
(journals.asm.org)
|
Ireland RE
…
Nelson M
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#infection
#treatment
#antibiotic
#tularemia
#inhalation
|
|
0
|
|
Effectiveness and safety of meropenem-vaborbactam versus ceftazidime-avibactam in multidrug-resistant Gram-negative infections: a systematic review and meta-analysis with trial sequential analysis.
(journals.asm.org)
|
Mohammad S
…
Almangour TA
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#infection
#amr
#meta-analysis
#treatment
|